Publicaciones en las que colabora con José Luis López-Campos Bodineau (27)

2024

  1. A Pilot Study on Proteomic Predictors of Mortality in Stable COPD

    Cells, Vol. 13, Núm. 16

  2. COPD: systemic proteomic profiles in frequent and infrequent exacerbators

    ERJ Open Research, Vol. 10, Núm. 2

  3. Diagnóstico precoz de cáncer de pulmón en muestras de suero previas a su diagnóstico clínico: Utilidad de la metabolómica

    Revista española de patología torácica, Vol. 36, Núm. 2, pp. 127-140

  4. Heteroatom-tagged proteomics of lung cancer and chronic obstructive pulmonary disease human serum reveal alterations in selenoproteins

    Microchemical Journal, Vol. 199

  5. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

2023

  1. Diagnóstico precoz de cáncer de pulmón mediante metabolómica aplicada a muestras de suero previas a su diagnóstico clínico

    Revista española de patología torácica, Vol. 35, Núm. 1, pp. 42-42

  2. Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

  3. Untargeted Metabolomic Study of Lung Cancer Patients after Surgery with Curative Intent

    Journal of Proteome Research, Vol. 22, Núm. 11, pp. 3499-3507

2021

  1. COPD Clinical Control: predictors and long-term follow-up of the CHAIN cohort

    Respiratory research, Vol. 22, Núm. 1, pp. 36

  2. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex

    Chest, Vol. 160, Núm. 2, pp. 481-490

2020

  1. A delphi consensus document on the use of single-inhaler fixed-dose triple therapies in copd patients

    International Journal of COPD, Vol. 15, pp. 1801-1811

  2. A proposed approach to chronic airway disease (CAD) using therapeutic goals and treatable traits: A look to the future

    International Journal of COPD, Vol. 15, pp. 2091-2100

  3. Biomarcadores metabolómicos predictores de la caída del FEV1 en fumadores sanos y pacientes con EPOC ligera-moderada

    Revista española de patología torácica, Vol. 32, Núm. 1, pp. 37-37

  4. Mortality prediction in chronic obstructive pulmonary disease comparing the gold 2015 and gold 2019 staging: A pooled analysis of individual patient data

    ERJ Open Research, Vol. 6, Núm. 4, pp. 1-10

  5. Sex differences between women and men with COPD: A new analysis of the 3CIA study

    Respiratory Medicine, Vol. 171

2019

  1. The BIOMEPOC Project: Personalized Biomarkers and Clinical Profiles in Chronic Obstructive Pulmonary Disease

    Archivos de Bronconeumologia, Vol. 55, Núm. 2, pp. 93-99

2018

  1. Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort

    Chest, Vol. 154, Núm. 2, pp. 274-285

2017

  1. Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD

    The European respiratory journal, Vol. 50, Núm. 5

  2. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease

    Journal of the American Medical Directors Association, Vol. 18, Núm. 12, pp. 1097.e11-1097.e24

2016

  1. Defining the asthma-COPD overlap syndrome in a COPD Cohort

    Chest, Vol. 149, Núm. 1, pp. 45-52